BEAMSTART Logo

HomeNews

Israel's Femtech Innovator Escala Medical Secures $4.5M to Revolutionize Pelvic Organ Prolapse Treatment

Alfred LeeAlfred Lee14h ago

Israel's Femtech Innovator Escala Medical Secures $4.5M to Revolutionize Pelvic Organ Prolapse Treatment

Escala Medical, an innovative femtech company based in Misgav, Israel, has recently raised $4.5 million in a significant funding round. This investment marks a pivotal moment for the medical technology firm, which specializes in developing advanced repair solutions for women suffering from Pelvic Organ Prolapse (POP), a condition affecting millions globally.

The funding round included contributions from the EIC Fund, following a substantial €2.5 million grant awarded to Escala in October 2023 through the prestigious EIC Accelerator program. Additionally, the round saw participation from private investors in the United States and Israel, showcasing strong international confidence in Escala’s mission and technology.

Escala’s flagship device, already FDA-approved, has been commercially launched in the U.S. in 2023, with hundreds of successful procedures performed to date. The newly acquired funds will be utilized to expand commercial operations in the U.S. market and to prepare for entry into Europe, pending CE approval.

This financial boost will also support Escala’s plans for further international growth. The company aims to address the unmet needs of women worldwide by offering a groundbreaking, minimally invasive solution for POP, a condition that can severely impact quality of life.

With the femtech sector gaining increasing attention, Escala Medical stands at the forefront of innovation in women’s health. The company’s efforts are part of a broader movement in Israel, a hub for technological advancements, to empower solutions tailored to women’s unique medical challenges.

As Escala Medical continues to grow, this funding round signals a promising future for both the company and the millions of women who stand to benefit from its pioneering medical device. The global expansion of its technology could redefine standards in POP treatment, bringing hope and improved care to countless individuals.

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2025 BEAMSTART. All Rights Reserved.